Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multi-institutional Study.


Journal

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
ISSN: 1538-7151
Titre abrégé: Int J Gynecol Pathol
Pays: United States
ID NLM: 8214845

Informations de publication

Date de publication:
May 2019
Historique:
entrez: 9 4 2019
pubmed: 9 4 2019
medline: 3 8 2019
Statut: ppublish

Résumé

Uterine carcinosarcomas are rare aggressive biphasic neoplasms. Because of its rarity, limited data are available on potential prognostic parameters. While several studies support that carcinomatous components predict outcomes, others do not. In this study, we evaluated the clinical and histopathologic features of 196 uterine carcinosarcomas to identify potential prognostic factors. Patients' ages ranged from 34 to 95 yr (median, 68 yr). Seventy-three (38%) patients experienced tumor recurrence during follow-up. Tumors ≥5 cm, outer half myometrial invasion, lymphovascular invasion, lymph node metastasis, advanced stage (International Federation of Gynecology and Obstetrics stages III-IV), sarcomatous component on recurrence, sarcoma dominance, and positive cytology were significantly associated with shorter disease-free interval (P<0.05). In addition, serous histology and rhabdomyoblastic differentiation was significantly associated with worse 3-yr overall survival. Our data supports that both carcinomatous and sarcomatous components play a role in tumor progression and survival of uterine carcinosarcoma patients, suggesting their equal importance in guiding management decisions.

Identifiants

pubmed: 30958427
doi: 10.1097/PGP.0000000000000497
pii: 00004347-201905000-00001
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Pagination

205-215

Auteurs

Eman Abdulfatah (E)

Department of Pathology, Wayne State University (E.A., B.A., S.B., R.A.-F.) Department of Pathology, St John's Providence Hospital (M.K.), Detroit, Michigan Department of Pathology, Massachusetts General Hospital, Harvard University, Boston, Massachusetts (L.L., K.V.D.V., E.O.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH